Xiangxin Geng
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine, 1200 Cailun Road
Shanghai, 201203, China
Shanghai, 201203, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Paroxetine repurposing enhances antitumor immunity via SPOP-mediated PD-L1 ubiquitination and proteasomal degradation.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 02, 2025
Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1/2 and GPX4 in colorectal cancer.
Journal: Signal transduction and targeted therapy
Published: December 19, 2024
Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual-Targeting BMI1 for Senescence Induction and CSN5 for PD-L1 Degradation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 17, 2024
Network Medicine-Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD-L1 Expression via Targeting SPOP in Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 26, 2024
Demethylzeylasteral induces PD-L1 ubiquitin-proteasome degradation and promotes antitumor immunity via targeting USP22.
Journal: Acta pharmaceutica Sinica. B
Published: April 30, 2024
5,7,4'-Trimethoxyflavone triggers cancer cell PD-L1 ubiquitin-proteasome degradation and facilitates antitumor immunity by targeting HRD1.
Journal: MedComm
Published: February 28, 2024
Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3.
Journal: Cell reports. Medicine
Published: April 29, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026